McMullin MF, Harrison CN, Ali S, et al. A guideline for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol. 2023;200(4):455-470.
[2]
Cario H, McMullin MF, Bento C, et al. Erythrocytosis in children and adolescents - A series of 67 cases. Am J Hematol. 2022;97(5):E165-E168.
[3]
Lee FS, Percy MJ. The hypoxia-inducible factor pathway in erythrocytosis. Hematol Oncol Clin North Am. 2022;36(2):289-304.
[4]
Bento C, Percy MJ, Gardie B, et al. Genetic basis of congenital erythrocytosis: mutation update and online databases. Hum Mutat. 2021;42(3):234-252.
[5]
Johansson PL, Safai-Kutti S, Suo J, et al. Primary familial and congenital polycythemia: a diagnostic algorithm. Blood Cells Mol Dis. 2020;84:102413.
[6]
Patnaik MM, Tefferi A. The complete spectrum of JAK2-positive myeloproliferative neoplasms. Mayo Clin Proc. 2020;95(5):1022-1034.
[7]
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th Edition. Lyon: IARC Press; 2022.
[8]
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2023;127(20):2391-2405.